That had to be progressed within a fiscal straitjacket imposed by the EU-IMF.

The remainder progressed within 2 months of initiation of imatinib.

The tumor progressed within 6 weeks of chemotherapy to involve the diaphragm and the pericardium (inoperable disease).

The remaining 22 all progressed within 15 months of ABMR; three of 37 (8%) died of treatment-related complications.

CR was also obtained in two of five tumour nodules treated with cisplatin intratumorally, but the other three nodules progressed within 3-7 months.